ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2023

In Vivo Intra-Uterine Delivery of TAT-Fused Cre Recombinase and CRISPR/Cas9 Editing System in Mice Unveil Histopathology of Pten/p53-Deficient Endometrial Cancers.

Raúl Navaridas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.